Characteristics and Strength of Evidence of COVID-19 Studies Registered on ClinicalTrials.gov

JAMA Intern Med. 2020 Oct 1;180(10):1398-1400. doi: 10.1001/jamainternmed.2020.2904.

Abstract

This cross-sectional study evaluates the characteristics and expected strength of evidence of coronavirus disease 2019 studies registered on ClinicalTrials.gov.

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Clinical Trials as Topic
  • Coronavirus Infections* / epidemiology
  • Coronavirus Infections* / prevention & control
  • Coronavirus Infections* / therapy
  • Cross-Sectional Studies
  • Data Accuracy
  • Evidence-Based Medicine* / methods
  • Evidence-Based Medicine* / standards
  • Humans
  • Needs Assessment
  • Outcome Assessment, Health Care* / methods
  • Outcome Assessment, Health Care* / standards
  • Pandemics* / prevention & control
  • Pneumonia, Viral* / epidemiology
  • Pneumonia, Viral* / prevention & control
  • Pneumonia, Viral* / therapy
  • Registries
  • Research Design* / standards
  • Research Design* / statistics & numerical data
  • SARS-CoV-2